|
Market Closed -
NYSE
16:00:00 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 2.780 USD | 0.00% |
|
+2.58% | +54.44% |
| Market Cap | 224M 201M 187M 170M 320M 21.45B 322M 2.25B 880M 11.05B 841M 823M 35.53B | P/E 2026 * |
11.6x | P/E 2027 * | 55.6x |
|---|---|---|---|---|---|
| Enterprise Value | 224M 201M 187M 170M 320M 21.45B 322M 2.25B 880M 11.05B 841M 823M 35.53B | EV / Sales 2026 * |
2.73x | EV / Sales 2027 * | 3.37x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed | |
|
Boerse Muenchen
| PBDA | Real-time |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 week | +2.58% | ||
| Current month | +0.72% | ||
| 1 month | +5.30% | ||
| 3 months | +13.93% | ||
| 6 months | +20.87% | ||
| Current year | +54.44% |
| 1 week | 2.61 |  | 2.8 |
| 1 month | 2.6 | | 2.85 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Free | Director | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chief Executive Officer | 480,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +2.58% | +17.80% | +86.58% | 224M | |
| +0.28% | +3.46% | +41.89% | +93.71% | 1,051B | |
| +0.88% | +4.27% | +38.28% | +68.70% | 630B | |
| +1.68% | +5.78% | +21.96% | +89.56% | 489B | |
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | |
| +0.61% | +3.18% | +24.05% | +42.46% | 344B | |
| +0.72% | +2.99% | +14.29% | +34.71% | 272B | |
| +0.23% | +1.31% | -5.91% | +9.89% | 246B | |
| +0.65% | +3.62% | +43.93% | +46.50% | 224B | |
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | |
| Average | +0.45% | +2.83% | +29.38% | +60.85% | 380.39B | |
| Weighted average by Cap. | +0.57% | +2.93% | +34.07% | +67.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 73.64M 68.56M 62.21M 117M 7.87B 118M 824M 323M 4.05B 309M 302M 13.03B | 66.48M 59.59M 55.48M 50.34M 94.94M 6.37B 95.56M 667M 261M 3.28B 250M 244M 10.54B |
| Net income | 19.63M 17.6M 16.38M 14.86M 28.04M 1.88B 28.22M 197M 77.09M 968M 73.73M 72.1M 3.11B | 3.79M 3.4M 3.17M 2.87M 5.42M 363M 5.45M 38.07M 14.9M 187M 14.25M 13.93M 602M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-12 | US$2.780 | 0.00% | 714,233 |
| 26-10-09 | US$2.780 | +2.96% | 1,198,885 |
| 26-10-08 | US$2.700 | -0.37% | 972,851 |
| 26-10-07 | US$2.710 | -0.73% | 794,734 |
| 26-10-06 | US$2.730 | +0.74% | 934,737 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
